Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
about
Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion InjuryNeuroprotective Strategies during Cardiac Surgery with Cardiopulmonary BypassRNA Regulation by Poly(ADP-Ribose) PolymerasesA chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage responseThe structural basis of XRCC1-mediated DNA repairPoly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signalingThe histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1.PARP-1 enhances the mismatch-dependence of 5'-directed excision in human mismatch repair in vitroNew facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases.Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer.FMRP: a new chapter with chromatinInhibition of DNA damage repair by artificial activation of PARP with siDNA.Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription.PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in micePost-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins.PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas.Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathwayPARP-1 and PARP-2: New players in tumour development.Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1.Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.Genome-wide analysis of gene expression in human embryonic tooth germ.Role of PARP-1 in prostate cancer.Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.Dual roles of DNA repair enzymes in RNA biology/post-transcriptional control.Influence of reducing agents on the cytotoxic activity of platinum(IV) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines.Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agents.Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosisBioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactomeInvolvement of PARP1 in the regulation of alternative splicingSimvastatin ameliorates ionizing radiation-induced apoptosis in the thymus by activating the AKT/sirtuin 1 pathway in mice.Poly(ADP-ribose) polymerase 1 escorts XPC to UV-induced DNA lesions during nucleotide excision repair.Protective effects of an ethanol extract of Angelica keiskei against acetaminophen-induced hepatotoxicity in HepG2 and HepaRG cells.Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
P2860
Q26770727-4D32948D-56BA-436A-9BAC-590DC7357519Q28076954-B95A81CA-35A0-457B-89A8-95D4360F547AQ28080877-D4F6BBEC-A5FF-4D13-ADB9-F3E7826C160EQ28117547-3C1089EC-47CD-4671-81F0-21877B9978D6Q28259282-675DC85E-64CF-40E3-BA10-FA45E184ACCCQ33578933-2890DE8A-7814-422E-9931-806D766F9CF5Q33743684-9C34D0A3-C74D-44B1-8116-3F8105C6655FQ33843139-698C28E8-CC0C-4EDE-82AA-743795B58D59Q34030005-984D1D67-3D87-4EA7-A9CD-D930ABF17BADQ34042969-69D50724-9BC1-43E6-A908-08318AAE648FQ34513028-8A6A729C-1ED8-4EAD-9920-0BCBB5CA7ABCQ34657318-A5873EDC-5DEE-4224-BABE-147944132F54Q34769158-9D7A18A3-3DAB-4821-8731-746A8E190869Q34786448-32340EE5-BDB8-419B-A837-D000C8299987Q36056495-D6C28D38-2459-465B-B12B-ED003DB0EFF3Q37032976-968ED784-64DD-429F-9649-75F883844207Q37139138-5CC19E99-37ED-4A1F-9EB4-18B5E957E096Q37633440-1D8A70E3-69C8-406F-9A29-912798B6C04BQ37687329-407C22A1-6B61-4AF8-8595-50C244BDF73AQ37942024-277C6FD5-9236-4DE9-860F-FA887F5DD066Q37956668-6104CF47-45B8-433C-B333-6412038A7ACAQ38009733-289F0559-648E-4843-A120-EF3C5FBC89A0Q38134049-F05C559A-05B5-4B10-B737-38E232C19AD5Q38305247-86F261E0-017F-4CC6-8D4F-F63EEF84284FQ38526322-3C7E2AE2-15A6-4452-B05E-874BB995FEFDQ38604581-E11E02C6-841A-4921-9B87-454E8FD4C739Q38756892-6F356B4D-26B6-4208-998B-3771CF48F1DEQ38820585-54EDEC52-175D-4A9E-9563-6EEA4EBA82D8Q38864172-5B430FBD-4A17-4426-A1EC-022F0219E0C8Q38941125-F81B2359-75E4-43C6-848D-9B3C3B228356Q38991064-763EEB62-FAE4-4C50-9975-8157A20200FBQ39436775-9FD03CCF-F5F0-49BF-9017-77CC917DA8CAQ39447083-2A54AE91-3C36-467E-B83A-1FCFA9BDA136Q40991982-E8A496A1-A90C-48C8-AE78-5B6B4DC39D4BQ41189004-E1439F3D-5046-46FF-A7F6-5D7CEBD35ED5Q41296905-43A1D506-2C19-4ADC-8D85-8DAE12295013Q41477151-88D3BE91-8E64-4CBC-BEC5-F2916F312D6DQ42054933-88F8A981-B108-44B4-BEE5-2A8A758B1D94Q42072170-177ECAC2-4D13-4FFA-9EA6-5CCB88A1D012Q42701719-8734C685-B179-4E3E-9300-6AF169417419
P2860
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@ast
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en-gb
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@nl
type
label
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@ast
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en-gb
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@nl
prefLabel
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@ast
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en-gb
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@nl
P2093
P2860
P356
P1433
P1476
Investigation of PARP-1, PARP- ...... purification mass spectrometry
@en
P2093
Chantal Ethier
Guy G Poirier
Jean-Philippe Gagné
Maxim Isabelle
Michèle Rouleau
Pierre Gagné
Xavier Moreel
P2860
P2888
P356
10.1186/1477-5956-8-22
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1001102694